Treatment Trends and Factors Associated with Survival in T1aN0 and T1bN0 Breast Cancer Patients

By Kennedy Timothy  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2918-2927

Springer Publishing Company

Access to resources Recommend Favorite

Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer

By Xia Qing  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1719-1725

Springer Publishing Company

Access to resources Recommend Favorite

Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer

By Hamamoto Yasushi  

Breast Cancer, Vol. 20, Iss. 3, 2013-07 ,pp. : 218-222

Springer Publishing Company

Access to resources Recommend Favorite

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2- neu -positive breast cancer? A current debate

By Petrelli Fausto  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 401-408

Humana Press, Inc

Access to resources Recommend Favorite

Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer

By Djärv Emma   Nyman Jan   Baumann Pia   Ekberg Lars   Høyer Morten   Lax Ingmar   Lewensohn Rolf   Levin Nina   Lund Jo-Åsmund   Morhed Elisabeth   Ericsson Susanne Rehn   Traberg Anders   Wittgren Lena   Johansson Karl-Axel  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 973-977

Informa Healthcare

Access to resources Recommend Favorite